Skip to main content
. Author manuscript; available in PMC: 2014 Jul 31.
Published in final edited form as: Antivir Ther. 2013 Jul 31;18(8):1005–1013. doi: 10.3851/IMP2665

Figure 3. The correlation between cervical tissue (CT) and vaginal tissue (VT) dolutegravir (DTG) concentrations.

Figure 3

Individual concentration/time points are plotted for DTG in CT and VT. A significant (p=0.003) correlation is noted between CT and VT concentrations (rho=0.70). A line of unity is presented as reference.